All In MedTech

Device Trial Radar · NCT02263859

Targeted Hypoglossal Neurostimulation Study #3

ImThera Medical Targeted Hypoglossal Neurostimulation Study #3

Last checked: Nov 20, 2026Latest source record: Feb 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 138 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

138

Actual

Start

Feb 2015

Primary completion

Jun 2019

Study completion Sep 1, 2023

Sponsor

Lead sponsor
ImThera Medical, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
LivaNova
First posted
Oct 13, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the benefits and risks of hypoglossal nerve stimulation with the ImThera Medical aura6000 System as a potential therapeutic option for individuals with moderate to severe OSA that have failed or do not tolerate PAP.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • aura6000 SystemDevice

    The aura6000 System is intended to unilaterally stimulate the hypoglossal nerve which innervates the muscles of the tongue. The aura6000 System stimulates the hypoglossal nerve cyclically and continuously during sleep to maintain muscle tone of the tongue and upper airway during sleep. Stimulation is generated by a programmable, multi-current source, implantable neurostimulator (IPG) and delivered to the hypoglossal nerve by a lead with multi-contact cuff electrode (lead).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement in Apnea Hypopnea Index (AHI)Time frame: Baseline to 4 months post-implant
  2. Improvement in Oxygen Desaturation Index (ODI)Time frame: Baseline to 4 months post-implant
  3. Safety AnalysisTime frame: Baseline to 12 months post-implant

Locations

20 sites in 6 countries. Site status is shown where the registry gives one.

  • ENT Associates of San Diego

    Chula Vista, California

  • Tower ENT

    Los Angeles, California

  • SENTA Clinic

    San Diego, California

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.